The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Residual cancer burden (RCB) as prognostic in the I-SPY 2 TRIAL.
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Intellectual property
Travel, Accommodations, Expenses - Luminex
 
Christina Yau
Employment - NantWorks
 
Yunn-Yi Chen
No Relationships to Disclose
 
Brian Datnow
No Relationships to Disclose
 
Shi Wei
No Relationships to Disclose
 
Michael D Feldman
No Relationships to Disclose
 
Jon Ritter
No Relationships to Disclose
 
Xiuzhen Duan
No Relationships to Disclose
 
Beiyun Chen
No Relationships to Disclose
 
Ronald Tickman
No Relationships to Disclose
 
Husain Sattar
No Relationships to Disclose
 
Anthony Martin Magliocco
No Relationships to Disclose
 
Bhaskar Kallakury
No Relationships to Disclose
 
Megan Troxell
No Relationships to Disclose
 
Smita Asare
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Seagen (Inst)
 
Minetta C. Liu
Research Funding - Eisai (Inst); GRAIL (Inst); Janssen Diagnostics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Agena Bioscience; Celgene; Cynvenio Biosystems; GRAIL; Menarini Silicon Biosystems; Merck
 
Angela DeMichele
Honoraria - Pfizer; Pfizer
Consulting or Advisory Role - Calithera Biosciences; Novartis
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Millennium (Inst); Pfizer (Inst); Veridex (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - Calithera Biosciences; Novartis; Pfizer
 
Douglas Yee
Consulting or Advisory Role - Boehringer Ingelheim; Genentech Mypath; Symphony Evolution
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Laura Esserman
Consulting or Advisory Role - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech